All News

The agency also denied 3 citizen petitions asking for CBD products to be marketed as dietary supplements.

There's no better time to remind pharmacists that they are vital in the fight against CVD.

Investigators emphasize the importance of a timely HLH diagnosis and prompt initiation of treatment, as well as close outpatient follow-up to increase patient survival.

Moderator Curtis E. Haas, PharmD, FCCP; Deborah Simonson, PharmD; Andrew J. Donnelly, PharmD, MBA, FASHP; Noelle Chapman, PharmD, MBA, BCPS, FASHP; Todd Nesbit, PharmD, MBA, FASHP, discuss current challenges facing health-system pharmacies as well as potential solutions in areas such as staffing and financial stress.

Social media can leverage pharmacists as personalities and help influence which topics the public discusses and the data they consume, presenter says.

Lisocabtagene maraleucel is a CD19-directed CAR T-cell therapy with a 4-1BB costimulatory domain, which enhances the expansion and persistence of the CAR T cells.

The updated label now includes patients with cold agglutinin disease with or without a history of transfusions.

A community-based multidisciplinary team can have a significant impact addressing health disparities and diabetes management.

Economic food insecurity, associated with cardiovascular mortality, disproportionately impacts Black communities.

Pharmacists want you to be on time.

The efficacy and adverse effects associated with COVID-19 vaccines is a leading cause of hesitancy in parents, according to a new study.

The FDA approved a new azole antifungal for recurrent vulvovaginal candidiasis.

The test, called VirSNiP SARS-CoV-2 Spike F486P, is for research use only and specifically targets the unique mutation F486P found within the XBB.1.5 Omicron sub-variant.

Pudlo’s presentation focused on key shifts in chain pharmacies, including pharmacy benefit manager (PBM) reform, pharmacist-administered vaccine trends, and provider status.

The moves come after other efforts to improve staff shortages, including higher wages, lunch breaks, and signing bonuses.

Comprehensive medication management is 1 way to optimize therapy, according to Steven Chen, PharmD, FASHP, FCSHP, FNAP, who spoke at the NACDS Regional 2023 Meeting.

Spinal cord stimulation has been used for 50 years to effectively manage chronic pain without opioids.

National Association of Chain Drug Stores CEO and president, and 2 other experts discuss the importance of advocacy on the statewide policy level.

With the growing importance of pharmacy services, Chen said pharmacists should think outside the box and get creative when finding effective payment models.

Variety of interventions improves morbidity, mortality, associated costs for patients with chronic obstructive pulmonary disorder.

Case studies address questions about a patient with type 2 diabetes and a patient who is curious about nicotine replacement therapy.

Promising results for lecanemab's efficacy in patients with mild cognitive impairment or mild dementia associated with Alzheimer disease were accompanied by reports of adverse effects associated with treatment.

Pharmacists should be vigilant in recognizing medications that are causing insomnia in a patient's profile or electronic medical record.

Mortality was highest among Asian, Black, and Hispanic populations, American Heart Association’s 2023 Statistical Update shows.

Consuming soy flour rich in B-conglycinin also promotes liver homeostasis, which may prevent atherosclerosis and fatty liver disease, research results show.

By setting a standard for prescriptions that improves member access, outcomes, and experience, we will establish a path forward for every facet of health care.

Jim Whitman, senior vice president of member programs and services at the National Association of Chain Drug Stores (NACDS), discussed the upcoming NACDS 2023 Regional Conference and what attendees can look forward to.

The FDA has approved pirtobrutinib (Jaypirca) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma following at least 2 lines of systemic therapy, including a Bruton tyrosine kinase inhibitor.